Betoptic S Suspension/ Drops
Product Images NDC 0078-0729

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Betoptic S (NDC 0078-0729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 0078-0729-10 Betoptic S® (betaxolol Hci Ophthalmic Suspension) 0.25% As Base 10 mL Sterile Novartis (Carton)

Principal Display Panel									Ndc 0078-0729-10									Betoptic S®									(betaxolol Hci Ophthalmic Suspension) 0.25% As Base									10 mL Sterile									Novartis (Carton)
Betoptic S is an ophthalmic suspension containing 0.25% betaxolol HCI as a base, used for topical application in the eyes. The solution is sterile, and each mL contains 0.019% of inactive ingredients. The product is manufactured by Aoon Laboratories and is distributed by Novartis Pharmaceuticals Corporation. It comes in a 10mL sterile bottle and should be stored at 25°C. The product is available by prescription only, and the GTIN is 0300780720109.*
FDA Label Image

Chemical (Chemical)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.